Company profile ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The...
ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment...
System T Performances: Annual Compound Profit 40%, Win Rate 55%, Risk/Reward Ratio 1:2, 20 Years of Backtesting Data, Over 100 Markets. * Click Like and Follow to Support My Work! --- Hi Traders, I'd like to introduce the System T, a computerized trading system that analyzed and backtested the 20 years history data of over 100 markets. This post is my sharing...
COMPANY PROFILE ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The...
watch for a break through resistance, multi-month cup with handle. healthcare sector, strong earnings.
high vol, strong earnings announcement, increasing dividend, health space
Medical devices holding company ResMed Inc. NYSE:RMD is looking good at these levels. With announcements due on the 24th I'm looking for the trend to continue if the results live up to expectations.
Looks liquid enough for a bounce on monday. Always be careful and use a tight SL!
Resmed - RMD share price broke the key resistance level, closed the week to $16.33. In the past 54 weeks the Resmed shares price have jumped around 46 per cent from $10.99 to $16.33, with the stock trading near its all-time high of $16.39. RSI confirmed a bullish signal. The shares price profit target is around 8 per cent or $17.06. ASX:RMD
Beautiful wedgie. Earnings out tonight ATB - still long since Dec11. Technically strong, fundementally sound!!
25 Jan is the day publishing the Q4 report, also is the possible point of time when it reaches it resistance line. Whether go up or down, that day counts!
Bounce off resistance and accum, but if it pokes, should run nicely. Long pos taken early @ $114.55
$RMD - Resmed making a comeback? Increasing obesity and associated sleep apnea should further the demand for their products. Might be a good one for longer term buy and hold like SMSF. ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications...
An intraday high potential, Back Tested Long Analysis. We ll try to find an entry price within the expected pull back zone 102.52 - 103.58 as previously being back tested. DETAILS ON THE CHART NOTE: Entry range area above the entry point, is calculated upon 80% of the recorded pullback back tested past performances DISCLAIMER: This is a technical analysis...